CollPlant Biotechnologies Ltd Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CollPlant Biotechnologies Ltd (CLGN) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $6.07 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-26
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $6.07M 20-F · filed 2026-03-26 | |
| 2024-12-31 | $3.50M 20-F · filed 2025-03-26 | |
| 2023-12-31 | -$3.93M 20-F · filed 2024-04-04 | |
| 2022-12-31 | $6.65M 20-F · filed 2023-03-29 | |
| 2021-12-31 | $159.00K 20-F · filed 2022-03-24 | |
| 2020-12-31 | $2.10M 20-F · filed 2022-03-24 | $572.00K 20-F · filed 2021-03-26 |
| 2019-12-31 | $2.48M 20-F · filed 2022-03-24 | |
| 2018-12-31 | -$232.00K 20-F · filed 2021-03-26 |